130 Episodo

  1. Do You Really Lose Muscle on Semaglutide or Tirzepatide?

    Publicado: 22/8/2025

  2. Predatory Lab Testing: What They’re Not Telling You

    Publicado: 16/8/2025

  3. CVS Pulled the Plug on Zepbound?!

    Publicado: 8/8/2025

  4. More Than Weight Loss? GLP-1s and Cardiovascular Risk

    Publicado: 3/8/2025

  5. Semaglutide vs. Tirzepatide: Are We Closing the Gap?

    Publicado: 24/7/2025

  6. Clinical vs Anthropometric Obesity

    Publicado: 2/7/2025

  7. GLP-1 meds and macular degeneration

    Publicado: 23/6/2025

  8. Menopause, MHT, and GLP-1 medicines

    Publicado: 12/6/2025

  9. The Science of Myostatin inhibitors, GLP-1 meds and Muscle Mass

    Publicado: 6/6/2025

  10. Current State of Nutrition Research and MAHA

    Publicado: 29/5/2025

  11. Joy Prescriptions

    Publicado: 13/5/2025

  12. Zepbound versus Wegovy

    Publicado: 12/5/2025

  13. Semaglutide for metabolic dysfunction associated steatotic liver disease (MASH).

    Publicado: 2/5/2025

  14. Top 5 Women's Fitness Myths

    Publicado: 25/4/2025

  15. GLP-1 and metabolism and depression

    Publicado: 11/4/2025

  16. Do GLP-1 meds cause more fat cells?

    Publicado: 19/3/2025

  17. Future of medicine - Direct Care

    Publicado: 11/3/2025

  18. Tirzepatide and Muscle Loss with Dr. Grant Tinsley

    Publicado: 28/2/2025

  19. The Super Bowl Hims and Hers Ad

    Publicado: 17/2/2025

  20. NAD and NMN with Dr. Charles Brenner

    Publicado: 12/2/2025

1 / 7

Drs. Spencer and Karl Nadolsky talk about nutrition, medicine, and fitness through the lens of two physicians who lift weights. Both doctors are former NCAA division 1 wrestlers who have gone into medicine. Dr. Spencer Nadolsky is a board certified family physician specialized in obesity medicine and lipidology. Dr. Karl Nadolsky is a board certified endocrinologist also specialized in obesity medicine.

Visit the podcast's native language site